Mother of three sheds 10 stone in 16 months using diabetes drug Mounjaro

A 41-year-old mother of three has transformed her health after turning to weight loss injections. Tina Bashford, who once weighed 23 stone 7 lbs, lost over 10 stone in just 16 months using Mounjaro. Her journey began after a prediabetes diagnosis left her fearing for her future.

Tina had battled obesity since childhood. By the time she had her third daughter, she weighed 23st 7lbs and wore a size 26. In June 2024, doctors diagnosed her as prediabetic and suggested weight loss surgery abroad.

She decided to try Mounjaro instead. The drug, licensed for type 2 diabetes and clinical obesity, suppresses appetite by making users feel fuller for longer. Within the first month, Tina lost 1 stone 2 lbs and noticed the injections 'stopped the food noise'.

Over 16 months, she spent £2,000 on weekly doses, starting at 2.5 mg and gradually increasing. The results were dramatic: she shed over 10 stone, reversed her prediabetes, and now fits into size 12-14 clothes.

Meanwhile, demand for GLP-1 drugs like Mounjaro and Ozempic is rising. Around 8,000 NHS patients accessed Wegovy via the Oviva app in 2024, with 35,000 attending obesity clinics. Experts suggest up to a third of the UK population could qualify. Factors like app-based delivery, shorter waiting lists, and growing NHS eligibility may double user numbers within a year.

Tina's weight loss has reversed her prediabetes and cut her risk of serious illness. Her story comes as more people turn to GLP-1 medications for obesity management. With NHS services expanding, access to these treatments could grow significantly in the near future.